Helena Verdaguer

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

Rocio García‐Carbonero, Miriam Bazán‐Peregrino, Marta Gil-Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 75 citations · Full text

Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights

Rodrigo Dienstmann, Élena Elez, Guillem Argilés et al. · Molecular Oncology · 2017 · 54 citations · Full text

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

Andrea Herencia-Ropero, Alba Llop‐Guevara, Anna D. Staniszewska et al. · Genome Medicine · 2024 · 48 citations · Full text

Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma

Margherita Rimini, Teresa Macarulla, Valentina Burgio et al. · European Journal of Cancer · 2022 · 23 citations

Surgical Oncology, Hepatology, Clinical Implication +11

Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation

Queralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros et al. · Clinical Cancer Research · 2022 · 21 citations · Full text